These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6324985)

  • 1. The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study.
    Schron DS; Gipson T; Mendelsohn G
    Cancer; 1984 Jun; 53(11):2478-80. PubMed ID: 6324985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary adenocarcinomas of the prostate. An immunohistochemical study.
    Kuhajda FP; Gipson T; Mendelsohn G
    Cancer; 1984 Oct; 54(7):1328-32. PubMed ID: 6205741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
    Simon RA; di Sant'Agnese PA; Huang LS; Xu H; Yao JL; Yang Q; Liang S; Liu J; Yu R; Cheng L; Oh WK; Palapattu GS; Wei J; Huang J
    Hum Pathol; 2009 Feb; 40(2):252-8. PubMed ID: 18835619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.
    Ro JY; Têtu B; Ayala AG; Ordóñez NG
    Cancer; 1987 Mar; 59(5):977-82. PubMed ID: 2434204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
    Parwani AV; Ali SZ
    Diagn Cytopathol; 2002 Aug; 27(2):75-9. PubMed ID: 12203872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Composite carcinoma of the prostate combining a small cell carcinoma and an adenocarcinoma. Apropos of a case].
    Kantelip B; Viallard JL; Costes-Chalret N; Francannet P
    Ann Pathol; 1989; 9(2):121-5. PubMed ID: 2544191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method.
    Ansari MA; Pintozzi RL; Choi YS; Ladove RF
    Am J Clin Pathol; 1981 Jul; 76(1):94-8. PubMed ID: 7020410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of small cell carcinoma of the prostate].
    Murao T; Tanahashi T
    Gan No Rinsho; 1988 Sep; 34(11):1624-8. PubMed ID: 2846913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell carcinoma of the prostate gland with inappropriate antidiuretic hormone secretion: morphological, immunohistochemical and clinical expressions.
    Ghandur-Mnaymneh L; Satterfield S; Block NL
    J Urol; 1986 Jun; 135(6):1263-6. PubMed ID: 2423710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
    Bartziota EV
    Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving concepts in prostatic neuroendocrine manifestations: from focal divergent differentiation to amphicrine carcinoma.
    Bellur S; Van der Kwast T; Mete O
    Hum Pathol; 2019 Mar; 85():313-327. PubMed ID: 30481509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
    Bentz MS; Cohen C; Demers LM; Budgeon LR
    Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic origin of tumors. An immunohistochemical study.
    Nadji M; Tabei SZ; Castro A; Chu TM; Morales AR
    Am J Clin Pathol; 1980 Jun; 73(6):735-9. PubMed ID: 6156593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary carcinoma of the prostate, location, morphology, and immunohistochemistry: the histogenesis and entity of so-called endometrioid carcinoma.
    Wernert N; Lüchtrath H; Seeliger H; Schäfer M; Goebbels R; Dhom G
    Prostate; 1987; 10(2):123-31. PubMed ID: 2436204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma.
    van Haaften-Day C; Raghavan D; Russell P; Wills EJ; Gregory P; Tilley W; Horsfall DJ
    Prostate; 1987; 11(3):271-9. PubMed ID: 2825148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
    Epstein JI; Woodruff JM
    Cancer; 1986 Jan; 57(1):111-9. PubMed ID: 2416422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.